• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾源性单一钙结石的形成。患者的临床和实验室特征。

Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients.

作者信息

Strauss A L, Coe F L, Parks J H

出版信息

Arch Intern Med. 1982 Mar;142(3):504-7.

PMID:7065787
Abstract

Of 859 consecutive patients with calcium renal stones, 182 had formed only one stone before entering our program. Ninety-three (51.1%) had idiopathic hypercalciuria or hyperuricosuria; 36 (19.8%) others had a systemic disorder producing stones. The remainder, 53 (29.1%) patients, had no metabolic disorder. The frequency of hypercalciuria was lower than among patients with multiple stones. Compared with recurrent stone formers, patients with single stones were older when they passed their stones, suffered higher rates of complication such as surgery, cystoscopy, and urinary tract infection, and had a lower frequency of idiopathic hypercalciuria. During treatment, 11% formed a new stone in an average follow-up period of three years, a relapse rate similar to that of multiple stone formers; however, those patients with single stones who did relapse formed new stones at lower rates than multiple stone formers. Compared with recurrent stone formers, patients with solitary stones were more often treated with diet alone. Since there were no substantial differences between solitary and recurrent stone disease, patients who have formed a single stone should be evaluated and they should be treated no differently from other patients with stone disease.

摘要

在859例连续性肾钙结石患者中,182例在进入我们的研究项目之前仅形成过一枚结石。其中93例(51.1%)患有特发性高钙尿症或高尿酸尿症;另外36例(19.8%)患有导致结石形成的全身性疾病。其余53例(29.1%)患者没有代谢紊乱。高钙尿症的发生率低于多发结石患者。与复发性结石形成者相比,单发结石患者排出结石时年龄更大,手术、膀胱镜检查和尿路感染等并发症的发生率更高,特发性高钙尿症的发生率更低。在治疗期间,在平均三年的随访期内,11%的患者形成了新结石,复发率与多发结石形成者相似;然而,那些复发的单发结石患者形成新结石的几率低于多发结石形成者。与复发性结石形成者相比,孤立性结石患者更多仅接受饮食治疗。由于孤立性结石病和复发性结石病之间没有实质性差异,因此对于已形成单发结石的患者应进行评估,并且他们的治疗方式应与其他结石病患者无异。

相似文献

1
Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients.肾源性单一钙结石的形成。患者的临床和实验室特征。
Arch Intern Med. 1982 Mar;142(3):504-7.
2
Metabolic abnormalities associated with calyceal diverticular stones.与肾盏憩室结石相关的代谢异常。
BJU Int. 2006 May;97(5):1053-6. doi: 10.1111/j.1464-410X.2006.06134.x.
3
Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder.特发性高钙尿症、高尿酸尿症或无代谢紊乱患者的复发性钙肾结石的治疗与未治疗情况。
Ann Intern Med. 1977 Oct;87(4):404-10. doi: 10.7326/0003-4819-87-4-404.
4
[Studies of urinary risk factors in urolithiasis].[尿路结石的尿液危险因素研究]
Hinyokika Kiyo. 1985 Jan;31(1):1-15.
5
Calcium-uric acid nephrolithiasis.钙尿酸肾结石病
Arch Intern Med. 1978 Jul;138(7):1090-3.
6
The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.别嘌醇治疗对高尿酸尿草酸钙结石形成者结石形成的影响。
Scand J Urol Nephrol Suppl. 1980;53:265-71.
7
Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.代谢风险因素及药物治疗对肥胖患者肾结石管理的影响。
J Urol. 2004 Jul;172(1):159-63. doi: 10.1097/01.ju.0000128574.50588.97.
8
Urinary risk factors for recurrent calcium stone formation in Thai stone formers.泰国结石患者复发性钙结石形成的尿液危险因素。
J Med Assoc Thai. 2007 Apr;90(4):688-98.
9
Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.伴有和不伴有原发性甲状旁腺功能亢进的钙结石形成者的临床和实验室特征。
BJU Int. 2009 Mar;103(5):670-8. doi: 10.1111/j.1464-410X.2008.08064.x. Epub 2008 Sep 12.
10
[Functional evaluation in patients with kidney calculi].[肾结石患者的功能评估]
Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):394-8.

引用本文的文献

1
Predictors of Symptomatic Kidney Stone Recurrence After the First and Subsequent Episodes.首次及后续发作后症状性肾结石复发的预测因素。
Mayo Clin Proc. 2019 Feb;94(2):202-210. doi: 10.1016/j.mayocp.2018.09.016. Epub 2018 Dec 4.
2
Defining metabolic activity of nephrolithiasis - Appropriate evaluation and follow-up of stone formers.确定肾结石的代谢活性 - 结石形成者的适当评估与随访
Asian J Urol. 2018 Oct;5(4):235-242. doi: 10.1016/j.ajur.2018.06.007. Epub 2018 Jun 26.
3
24-h urine metabolic profile: is it necessary in all kidney stone formers?
24小时尿液代谢谱:是否所有肾结石患者都需要检测?
Int Urol Nephrol. 2018 Jul;50(7):1243-1247. doi: 10.1007/s11255-018-1902-1. Epub 2018 Jun 6.
4
Calcium urolithiasis course in young stone formers is influenced by the strength of family history: results from a retrospective study.年轻结石患者的钙结石病程受家族史强度的影响:一项回顾性研究的结果。
Urolithiasis. 2017 Dec;45(6):525-533. doi: 10.1007/s00240-016-0955-9. Epub 2016 Dec 9.
5
An Increase Incidence in Uric Acid Nephrolithiasis: Changing Patterns.尿酸肾结石发病率上升:变化趋势
J Clin Diagn Res. 2016 Jul;10(7):BC01-3. doi: 10.7860/JCDR/2016/19714.8139. Epub 2016 Jul 1.
6
Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.钙肾结石及其全身表现的代谢诊断与医学预防:共识声明
J Nephrol. 2016 Dec;29(6):715-734. doi: 10.1007/s40620-016-0329-y. Epub 2016 Jul 25.
7
Coronary Artery Calcium Score and Association with Recurrent Nephrolithiasis: The Multi-Ethnic Study of Atherosclerosis.冠状动脉钙化评分及其与复发性肾结石的关联:动脉粥样硬化的多民族研究。
J Urol. 2016 Apr;195(4 Pt 1):971-6. doi: 10.1016/j.juro.2015.10.001. Epub 2015 Oct 8.
8
The ROKS nomogram for predicting a second symptomatic stone episode.用于预测第二次有症状结石发作的韩国海军舰艇列线图。
J Am Soc Nephrol. 2014 Dec;25(12):2878-86. doi: 10.1681/ASN.2013091011. Epub 2014 Aug 7.
9
Differences in quantitative urine composition in stone-forming versus unaffected mate kidneys.结石形成的肾脏与未受影响的配对肾脏在尿液定量成分上的差异。
Open Access J Urol. 2009 Aug 24;1:9-13. doi: 10.2147/rru.s6580. eCollection 2009.
10
Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones.随机对照试验:非布司他对比别嘌醇或安慰剂治疗高尿酸尿症合并钙结石患者
Clin J Am Soc Nephrol. 2013 Nov;8(11):1960-7. doi: 10.2215/CJN.01760213. Epub 2013 Aug 8.